FDA Inspection 1000037 — King Pharmaceuticals LLC

King Pharmaceuticals LLC — FEI 1876582

The FDA completed an inspection of King Pharmaceuticals LLC on November 21, 2016 in Rochester, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 21, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rochester, MI (United States)

Citations

IDCFRDescription
144821 CFR 211.111Establishment of time limitations
430621 CFR 211.80(a)Written Procedures Not Followed